Adlai Nortye Group Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
15.62
+0.11 (0.71%)
At close: Oct 9, 2026, 4:00 PM EDT
16.70
+1.08 (6.91%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Adlai Nortye Group Market Cap
Adlai Nortye Group has a market cap or net worth of $1.01 billion as of October 9, 2026. It is the 10,272nd most valuable company in the world and the 2,239th biggest in the United States. Its market cap has increased by 1,475.71% in one year.
Market Cap
1.01B
Enterprise Value
799.78M
1-Year Change
1,475.71%
Global Rank
Country Rank
#2,239 United States
Category
ChartMarket Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye Group's market cap has increased from $553.50M to $1.01B, an increase of 81.73%. That is a compound annual growth rate of 21.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.01B | 1,819.71% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 1.15B |
| Avalyn Pharma | 1.14B |
| First Tracks Biotherapeutics | 1.13B |
| MannKind | 1.05B |
| MeiraGTx Holdings | 1.03B |
| Latigo Biotherapeutics | 1.03B |
| Cullinan Therapeutics | 1.01B |
| Immatics | 995.10M |